炎症性肠病患者新冠疫苗接种意愿与认知调查
COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-02-04
研究通过问卷调查识别IBD患者对疫苗接种的担忧,原文未报告具体样本量与结果数据。
要点
- IBD患者新冠感染率与普通人群相似,初始存在重症担忧。
- 研究调查IBD患者对新冠疫苗接种的潜在顾虑。
核心结论
- 研究通过调查IBD患者以识别其对新冠疫苗接种的潜在顾虑,原文未报告具体结论。
研究设计与样本
- 研究设计为对炎症性肠病患者进行问卷调查,原文未报告样本量与调查时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with inflammatory bowel disease (IBD) develop coronavirus disease 2019 (COVID-19) at similar rates as the general population, and there was initial concern regarding potential for severe illness.1-4 Vaccinations were authorized for emergency use in the United States in December 2020 and aim to halt the spread of COVID-19. However, there are concerns that people will be hesitant to receive the vaccine for a variety of reasons including insufficient data in certain populations including those with IBD. We surveyed patients with IBD to identify potential concerns regarding COVID-19 vaccination.
来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。
引用
- Dalal RS, McClure E, Marcus J, et al. COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021. PMID: 33549869. doi:10.1016/j.cgh.2021.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。